Literature DB >> 16760522

Development of antibodies to Burkholderia pseudomallei during childhood in melioidosis-endemic northeast Thailand.

Vanaporn Wuthiekanun1, Wirongrong Chierakul, Sayan Langa, Wipada Chaowagul, Chanathip Panpitpat, Penchan Saipan, Thaksinaporn Thoujaikong, Nicholas P Day, Sharon J Peacock.   

Abstract

A cross-sectional serological survey of 2,214 children living in northeast Thailand was conducted to define the antibody response to Burkholderia pseudomallei from birth to 14 years. There was a sharp rise in detectable antibodies from birth to 4 years followed by reactivity in approximately 60-70% of children thereafter.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16760522

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  39 in total

Review 1.  Human Melioidosis.

Authors:  I Gassiep; M Armstrong; R Norton
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

2.  A prospective study of melioidosis after environmental exposure of healthy participants to Burkholderia pseudomallei during a muddy endurance challenge.

Authors:  Rebecca Grivas; Sarah Barklay; Amber Ruane; Mark Mayo; Vanessa Theobald; Kevin Freeman; Robert Norton; Robert W Baird; Bart J Currie
Journal:  Am J Trop Med Hyg       Date:  2015-01-26       Impact factor: 2.345

3.  Surprisingly low seroprevalence of Burkholderia pseudomallei in exposed healthy adults in the Darwin region of tropical Australia where melioidosis is highly endemic.

Authors:  Gemma L James; Ben Delaney; Linda Ward; Kevin Freeman; Mark Mayo; Bart J Currie
Journal:  Clin Vaccine Immunol       Date:  2013-03-27

4.  Alteration of the phenotypic and pathogenic patterns of Burkholderia pseudomallei that persist in a soil environment.

Authors:  Yao-Shen Chen; Wun-Ju Shieh; Cynthia S Goldsmith; Maureen G Metcalfe; Patricia W Greer; Sherif R Zaki; Hsin-Hou Chang; Hao Chan; Ya-Lei Chen
Journal:  Am J Trop Med Hyg       Date:  2014-01-20       Impact factor: 2.345

Review 5.  Clinical features and epidemiology of melioidosis pneumonia: results from a 21-year study and review of the literature.

Authors:  Ella M Meumann; Allen C Cheng; Linda Ward; Bart J Currie
Journal:  Clin Infect Dis       Date:  2011-11-04       Impact factor: 9.079

6.  Accuracy of enzyme-linked immunosorbent assay using crude and purified antigens for serodiagnosis of melioidosis.

Authors:  Narisara Chantratita; Vanaporn Wuthiekanun; Aunchalee Thanwisai; Direk Limmathurotsakul; Allen C Cheng; Wirongrong Chierakul; Nicholas P J Day; Sharon J Peacock
Journal:  Clin Vaccine Immunol       Date:  2006-11-08

7.  Management of accidental laboratory exposure to Burkholderia pseudomallei and B. mallei.

Authors:  Sharon J Peacock; Herbert P Schweizer; David A B Dance; Theresa L Smith; Jay E Gee; Vanaporn Wuthiekanun; David DeShazer; Ivo Steinmetz; Patrick Tan; Bart J Currie
Journal:  Emerg Infect Dis       Date:  2008-07       Impact factor: 6.883

8.  The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study.

Authors:  Bart J Currie; Linda Ward; Allen C Cheng
Journal:  PLoS Negl Trop Dis       Date:  2010-11-30

Review 9.  Burkholderia pseudomallei: Challenges for the Clinical Microbiology Laboratory.

Authors:  Peera Hemarajata; Jonathan D Baghdadi; Risa Hoffman; Romney M Humphries
Journal:  J Clin Microbiol       Date:  2016-09-21       Impact factor: 5.948

10.  Prevalence of melioidosis in the Er-Ren River Basin, Taiwan: implications for transmission.

Authors:  Hsun-Pi Su; Hsiao-Wei Yang; Ya-Lei Chen; Tien-Lin Ferng; Yu-Ling Chou; Tung-Ching Chung; Chang-Hsun Chen; Chuen-Sheue Chiang; Mei-Mei Kuan; Hsi-Hsun Lin; Yao-Shen Chen
Journal:  J Clin Microbiol       Date:  2007-06-27       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.